Neonatal Drug Therapy Manual

Acyclovir

Disclaimer: Official controlled document is the CHEO and Ottawa Hospital online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.

Updated March 5, 2024 - 2:29pm

Alternate Name(s): 
Zovirax
Classification: 
Antiviral
Original Date: 
March 1992
Revised Date: 
June 2012
Indications: 
  • Treatment of neonatal herpes simplex virus infection
  • Treatment of varicella zoster infection
Administration: 
  • IV intermittent infusion: over 1 hour
Dosage: 
  • < 32 weeks GA: 40 mg/kg/day divided Q12H
  • > 32 weeks GA: 60 mg/kg/day divided Q8H
Side Effects: 
  • Hematologic: decrease neutrophils and platelets
  • Hepatic: liver enzymes elevated
  • Local: phlebitis
  • Renal: increase in urea and serum creatinine, crystalluria-minimize by ensuring adequate hydration and slow infusion rate
Parameters to Monitor: 
  • Serum creatinine
  • Urine output
  • CBC
  • Liver enzymes
Reconstitution and Stability: 
  • Acyclovir 50 mg/mL
    • Take 5 mL (250 mg) and add to 45 mL D5W
    • Final concentration: 5 mg/mL

 

Compatibility: 

- Solutions Compatible: D5W, 0.9% NaCl

- Y-site Compatible: ampicillin, ceftazidime, cefuroxime, cefotaxime, clindamycin, dexamethasone, erythromycin, fluconazole, gentamicin, heparin, hydrocortisone sodium succinate, KCL, lorazepam, magnesium sulfate, morphine (10-50 mcg/mL), ranitidine, sodium bicarbonate, tobramycin, vancomycin.

Incompatible: dobutamine, dopamine, SMOF, TPN

Notes: 
  • Room Temperature
  • Refrigeration may result in the formation of a precipitate, which will redissolve at room temperature. Ensure to warm to room temperature 30 minutes before using. 
References: 

-Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook 9th-11th Editions. Hudson: Lexi-Comp Inc.; 2002-2004.

-Kimberlin DW, Lin C, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108:230-8.

-Trissel LA. Handbook on Injectable Drugs. 12th-13th Editions. Bethesda: American Society of Health-System Pharmacists; 2003-2005.

 -Young TE, Mangum B. Neofax(R). 13th-16th Editions. Raleigh: Acorn Publishing; 2000-2003.

The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.

CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.

Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.